Jim Pankovich

170-422 Richards St
Vancouver, BC V6B2Z4, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Leveraging Morphological Profiling for Mechanistic Elucidation of Metal-Based Anticancer Compounds.

Leveraging Morphological Profiling for Mechanistic Elucidation of Metal-Based Anticancer Compounds.

Journal: JACS Au

Published: March 11, 2026

BOLD-100 treatment induces systemic lipid crosstalk in metastatic colorectal carcinoma patients in a combination treatment with FOLFOX.

BOLD-100 treatment induces systemic lipid crosstalk in metastatic colorectal carcinoma patients in a combination treatment with FOLFOX.

Journal: iScience

Published: October 25, 2025

Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation.

Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation.

Journal: Molecular cancer research : MCR

Published: February 06, 2024

The Metallodrug BOLD-100 Is a Potent Inhibitor of SARS-CoV-2 Replication and Has Broad-Acting Antiviral Activity.

The Metallodrug BOLD-100 Is a Potent Inhibitor of SARS-CoV-2 Replication and Has Broad-Acting Antiviral Activity.

Journal: Biomolecules

Published: June 13, 2023

Utilization of Cancer Cell Line Screening to Elucidate the Anticancer Activity and Biological Pathways Related to the Ruthenium-Based Therapeutic BOLD-100.

Utilization of Cancer Cell Line Screening to Elucidate the Anticancer Activity and Biological Pathways Related to the Ruthenium-Based Therapeutic BOLD-100.

Journal: Cancers

Published: September 23, 2022

CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada.

CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada.

Journal: Current oncology (Toronto, Ont.)

Published: August 13, 2021

Novel Microbial-Based Immunotherapy Approach for Crohn's Disease.

Novel Microbial-Based Immunotherapy Approach for Crohn's Disease.

Journal: Frontiers in medicine

Published: December 19, 2018

Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis.

Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis.

Journal: Frontiers in immunology

Published: June 27, 2018

Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy.

Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy.

Journal: Oncoimmunology

Published: July 13, 2017

Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction.

Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction.

Journal: Open forum infectious diseases

Published: June 04, 2015

Gender disparities in HIV risk behavior and access to health care in St. Petersburg, Russia.

Gender disparities in HIV risk behavior and access to health care in St. Petersburg, Russia.

Journal: AIDS patient care and STDs

Published: May 09, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026